Osteopore (OSX) Stock Price, News & Analysis

Company Overview

Osteopore Limited engages in the design, development, and marketing of bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. The company has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$3.50 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: ASX:OSX
• CIK: N/A
• Web: www.osteopore.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$3.51 million
• Net Margins: -130.20%
• Pretax Margin: N/A
• Return on Equity: -314.00%
• Return on Assets: -42.76%

Debt

• Debt-to-Equity Ratio: 60.47
• Current Ratio: 1.36
• Quick Ratio: 6.05

Sales & Book Value

• Annual Sales: A$2.70 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 115,550,000
• Free Float: N/A
• Market Cap: A$3.50 million
• Optionable: Not Optionable
• Beta: 0.20